Pharma & Biotech

BioNxt Solutions has unveiled two significant strategic developments this week, targeting both its financial structure and its core product pipeline....

The biotechnology sector thrives on definitive catalysts, and Axsome Therapeutics is currently delivering a steady stream of them. This specialist...

Investors in Arcutis Biotherapeutics will gain fresh insight into the company’s performance on February 25. The dermatology-focused biotech firm announced...

A surge in derivatives trading, rather than a major product announcement, has placed Pfizer in the spotlight. This activity coincides...

The biotech sector is witnessing a remarkable event as ImmunityBio experiences a parabolic rally to begin the year. This surge...

BioNxt Solutions Inc. has announced a key preclinical milestone for its experimental multiple sclerosis therapy. The Canadian biotechnology firm’s innovative...

The CureVac share has officially been delisted from public markets, marking the conclusion of its independent trading history. This final...

Shares of Viking Therapeutics experienced a significant rally in today's trading session, marking a notable recovery after a volatile period...

Market analysts are pointing to a potential inflection point for Sangamo Therapeutics, with consensus estimates suggesting the biotech firm could...

The biopharmaceutical company Insmed presents a compelling case of commercial execution tempered by the inherent uncertainties of drug development. While...